Advertisement

Topics

Klaria Signs Exclusive Development, License And Supply Agreement With Purdue Pharma Canada For Acute Treatment Of Opioid Overdose (KL-00514)

20:00 EDT 8 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Klaria Signs Exclusive Development, License And Supply Agreement With Purdue Pharma Canada For Acute Treatment Of Opioid Overdose (KL-00514)

NEXT ARTICLE

More From BioPortfolio on "Klaria Signs Exclusive Development, License And Supply Agreement With Purdue Pharma Canada For Acute Treatment Of Opioid Overdose (KL-00514)"

Quick Search
Advertisement